These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 9607628)

  • 1. Molecular oncogene markers and their significance in cutaneous malignant melanoma.
    Konstadoulakis MM; Vezeridis M; Hatziyianni E; Karakousis CP; Cole B; Bland KI; Wanebo HJ
    Ann Surg Oncol; 1998; 5(3):253-60. PubMed ID: 9607628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
    Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
    Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes.
    Kalogeraki A; Garbagnati F; Darivianaki K; Delides GS; Santinami M; Stathopoulos EN; Zoras O
    Anticancer Res; 2006; 26(5A):3551-4. PubMed ID: 17094481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma.
    Böni R; Bantschapp O; Müller B; Burg G
    Dermatology; 1998; 196(3):288-91. PubMed ID: 9621133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of C-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma.
    Lazaris AC; Theodoropoulos GE; Aroni K; Saetta A; Davaris PS
    Virchows Arch; 1995; 426(5):461-7. PubMed ID: 7633656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
    PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 1 integrin expression in malignant melanoma predicts occult lymph node metastases.
    Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Kim DK; Das Gupta TK
    Surgery; 1995 Oct; 118(4):669-73; discussion 673-5. PubMed ID: 7570321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 70 and HLA-DR molecules tissue expression. Prognostic implications in colorectal cancer.
    Lazaris AC; Theodoropoulos GE; Davaris PS; Panoussopoulos D; Nakopoulou L; Kittas C; Golematis BC
    Dis Colon Rectum; 1995 Jul; 38(7):739-45. PubMed ID: 7607036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.
    Gershenwald JE; Mansfield PF; Lee JE; Ross MI
    Ann Surg Oncol; 2000 Mar; 7(2):160-5. PubMed ID: 10761797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.
    Slingluff CL; Stidham KR; Ricci WM; Stanley WE; Seigler HF
    Ann Surg; 1994 Feb; 219(2):120-30. PubMed ID: 8129482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
    Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
    Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
    White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
    Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
    Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.